Skip to main content

Table 4 KRAS status according to gender

From: KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients

Gender

KRASwild-type n (%)

KRASmutant n (%)

Total n (%)

5,174 (66.4)

2,623 (33.6)

7,797 (100)

Female

2,440 (65.2)

1,305 (34.8)

3,745 (100)

Male

2,734 (67.5)

1,318 (32.5)

4,052 (100)